The nature of immune responses to urinary tract infections

Nature Reviews Immunology

Volumn 15, Issue 10, 2015, Pages 655-663

  Abraham, Soman N ^a,b   Miao, Yuxuan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; PROBIOTIC AGENT;

ADAPTIVE IMMUNITY; BACTERIAL VIRULENCE; EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; MAST CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION; BACTERIAL INFECTION; BACTERIUM; BIOLOGICAL MODEL; CLASSIFICATION; ESCHERICHIA COLI; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

ADAPTIVE IMMUNITY; BACTERIA; BACTERIAL INFECTIONS; ESCHERICHIA COLI; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 84942824463     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3887     Document Type: Review

References (71)

1. Wu X. R., Kong X. P., Pellicer A., Kreibich G., & Sun T. T. Uroplakins in urothelial biology, function, and disease. Kidney Int. 75, 1153-1165 (2009
2. Grist M., & Chakraborty J. Identification of a mucin layer in the urinary bladder. Urology 44, 26-33 (1994
3. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med. 113 (Suppl. 1A), 14S-19S (2002
4. Foxman B., Barlow R., D'Arcy H., Gillespie B., & Sobel J. D. Urinary tract infection: self-reported incidence and associated costs. Ann. Epidemiol. 10, 509-515 (2000
5. Schaeffer A. J. Recurrent urinary tract infections in women. Pathogenesis and management. Postgrad. Med. 81, 51-58 (1987
6. Foxman B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 7, 653-660 (2010
7. Nicolle L. E. Urinary tract pathogens in complicated infection and in elderly individuals. J. Infect. Dis. 183 (Suppl. 1), S5-S8 (2001
8. Kurts C., Panzer U., Anders H. J., & Rees A. J. The immune system and kidney disease: basic concepts and clinical implications. Nat. Rev. Immunol. 13, 738-753 (2013
9. Spencer J. D., Schwaderer A. L., Becknell B., Watson J., & Hains D. S. The innate immune response during urinary tract infection and pyelonephritis. Pediatr. Nephrol. 29, 1139-1149 (2014
10. Akira S., & Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004
11. Ingersoll M. A., & Albert M. L. From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa. Mucosal Immunol. 6, 1041-1053 (2013
12. Ragnarsdottir B., Lutay N., Gronberg-Hernandez J., Koves B., & Svanborg C. Genetics of innate immunity and UTI susceptibility. Nat. Rev. Urol. 8, 449-468 (2011
13. Song J., et al. A novel TLR4 mediated signaling pathway leading to IL 6 responses in human bladder epithelial cells. PLoS Pathog. 3, e60 (2007
14. Nagamatsu K., et al. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc. Natl Acad. Sci. USA 112, E871-E880 (2015
15. Agace W. W., Hedges S. R., Ceska M., & Svanborg C. Interleukin 8 and the neutrophil response to mucosal gram-negative infection. J. Clin. Invest. 92, 780-785 (1993
16. Bates J. M., et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int. 65, 791-797 (2004
17. Mo L., et al. Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1 fimbriated Escherichia coli. Am. J. Physiol. Renal Physiol. 286, F795-F802 (2004
18. Saemann M. D., et al. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor 4 dependent mechanism. J. Clin. Invest. 115, 468-475 (2005
19. Flo T. H., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917-921 (2004
20. Goetz D. H., et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10, 1033-1043 (2002
21. Paragas N., et al. α-intercalated cells defend the urinary system from bacterial infection. J. Clin. Invest. 124, 2963-2976 (2014
22. Chromek M., et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12, 636-641 (2006
23. Valore E. V., et al. Human β-defensin 1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101, 1633-1642 (1998
24. Spencer J. D., et al. Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int. 80, 174-180 (2011
25. Danka E. S., & Hunstad D. A. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis. J. Infect. Dis. 211, 1164-1173 (2015
26. Jaillon S., et al. The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection. Immunity 40, 621-632 (2014
27. Bishop B. L., et al. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat. Med. 13, 625-630 (2007
28. Song J., et al. TLR4 mediated expulsion of bacteria from infected bladder epithelial cells. Proc. Natl Acad. Sci. USA 106, 14966-14971 (2009
29. Miao Y., Li G., Zhang X., Xu H., & Abraham S. N. A TRP channel senses lysosome neutralization by pathogens to trigger their expulsion. Cell 161, 1306-1319 (2015
30. Mulvey M. A., et al. Induction and evasion of host defenses by type 1 piliated uropathogenic Escherichia coli. Science 282, 1494-1497 (1998
31. Mysorekar I. U., Isaacson-Schmid M., Walker J. N., Mills J. C., & Hultgren S. J. Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection. Cell Host Microbe 5, 463-475 (2009
32. Shin K., et al. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472, 110-114 (2011
33. Haraoka M., et al. Neutrophil recruitment and resistance to urinary tract infection. J. Infect. Dis. 180, 1220-1229 (1999
34. Agace W. W., Patarroyo M., Svensson M., Carlemalm E., & Svanborg C. Escherichia coli induces transuroepithelial neutrophil migration by an intercellular adhesion molecule 1 dependent mechanism. Infect. Immun. 63, 4054-4062 (1995
35. Shahin R. D., Engberg I., Hagberg L., & Svanborg Eden C. Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local Gram-negative infection. J. Immunol. 138, 3475-3480 (1987
36. Hannan T. J., et al. Inhibition of cyclooxygenase 2 prevents chronic and recurrent cystitis. EBioMedicine 1, 46-57 (2014
37. Engel D. R., et al. CCR2 mediates homeostatic and inflammatory release of Gr1high monocytes from the bone marrow, but is dispensable for bladder infiltration in bacterial urinary tract infection. J. Immunol. 181, 5579-5586 (2008
38. Duell B. L., Carey A. J., Dando S. J., Schembri M. A., & Ulett G. C. Human bladder uroepithelial cells synergize with monocytes to promote IL 10 synthesis and other cytokine responses to uropathogenic Escherichia coli. PLoS ONE 8, e78013 (2013
39. Symington J. W., et al. ATG16L1 deficiency in macrophages drives clearance of uropathogenic E. coli in an IL 1β dependent manner. Mucosal Immunol. http://dx.doi.org/10.1038/mi.2015.7 (2015
40. Schiwon M., et al. Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium. Cell 156, 456-468 (2014
41. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173-182 (2006
42. Shelburne C. P., et al. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe 6, 331-342 (2009
43. Abraham S. N., & St John A. L. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10, 440-452 (2010
44. Abraham S., Shin J., & Malaviya R. Type 1 fimbriated Escherichia coli-mast cell interactions in cystitis. J. Infect. Dis. 183 (Suppl. 1), S51-S55 (2001
45. Chan C. Y., St John A. L., & Abraham S. N. Mast cell interleukin 10 drives localized tolerance in chronic bladder infection. Immunity 38, 349-359 (2013
46. Gur C., et al. Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells. Cell Host Microbe 14, 664-674 (2013
47. Engel D., et al. Tumor necrosis factor α- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect. Immun. 74, 6100-6107 (2006
48. Jones-Carson J., Balish E., & Uehling D. T. Susceptibility of immunodeficient gene-knockout mice to urinary tract infection. J. Urol. 161, 338-341 (1999
49. Sivick K. E., Schaller M. A., Smith S. N., & Mobley H. L. The innate immune response to uropathogenic Escherichia coli involves IL 17A in a murine model of urinary tract infection. J. Immunol. 184, 2065-2075 (2010
50. Deckmann K., et al. Bitter triggers acetylcholine release from polymodal urethral chemosensory cells and bladder reflexes. Proc. Natl Acad. Sci. USA 111, 8287-8292 (2014
51. Ratner J. J., Thomas V. L., Sanford B. A., & Forland M. Bacteria-specific antibody in the urine of patients with acute pyelonephritis and cystitis. J. Infect. Dis. 143, 404-412 (1981
52. Wei Y., et al. Activation of endogenous anti-inflammatory mediator cyclic AMP attenuates acute pyelonephritis in mice induced by uropathogenic Escherichia coli. Am. J. Pathol. 185, 472-484 (2014
53. Langermann S., et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276, 607-611 (1997
54. Brumbaugh A. R., & Mobley H. L. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev. Vaccines 11, 663-676 (2012
55. McLachlan J. B., et al. Mast cell activators: a new class of highly effective vaccine adjuvants. Nat. Med. 14, 536-541 (2008
56. Alteri C. J., Hagan E. C., Sivick K. E., Smith S. N., & Mobley H. L. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 5, e1000586 (2009
57. Thankavel K., et al. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J. Clin. Invest. 100, 1123-1136 (1997
58. Luthje P., et al. Estrogen supports urothelial defense mechanisms. Sci. Transl Med. 5, 190ra80 (2013
59. Chassin C., et al. Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin. J. Exp. Med. 204, 2837-2852 (2007
60. Schlager T. A., Hendley J. O., Wilson R. A., Simon V., & Whittam T. S. Correlation of periurethral bacterial flora with bacteriuria and urinary tract infection in children with neurogenic bladder receiving intermittent catheterization. Clin. Infect. Dis. 28, 346-350 (1999
61. Bollgren I., & Winberg J. The periurethral aerobic bacterial flora in healthy boys and girls. Acta Paediatr. Scand. 65, 74-80 (1976
62. Reid G. Probiotic agents to protect the urogenital tract against infection. Am. J. Clin. Nutr. 73, 437S-443S (2001
63. Abraham S. N., et al. Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D mannose receptors. Infect. Immun. 48, 625-628 (1985
64. Ferrieres L., Hancock V., & Klemm P. Biofilm exclusion of uropathogenic bacteria by selected asymptomatic bacteriuria Escherichia coli strains. Microbiology 153, 1711-1719 (2007
65. Lutay N., et al. Bacterial control of host gene expression through RNA polymerase II. J. Clin. Invest. 123, 2366-2379 (2013
66. Hannan T. J., Mysorekar I. U., Hung C. S., Isaacson-Schmid M. L., & Hultgren S. J. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 6, e1001042 (2010
67. Nielubowicz G. R., & Mobley H. L. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7, 430-441 (2010
68. Ulett G. C., et al. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr. Opin. Microbiol. 16, 100-107 (2013
69. Henderson J. P., et al. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog. 5, e1000305 (2009
70. Mulvey M. A., Schilling J. D., Martinez J. J., & Hultgren S. J. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl Acad. Sci. USA 97, 8829-8835 (2000
71. Gupta K., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 52, e103-e120 (2011